Details

Notice Regarding Interim Approach for Evaluating Cardiovascular Risk for New Antidiabetic Therapies to Treat Type 2 Diabetes Mellitus - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 19, 2025 · edition #1
Timestamp: 2025-04-19T07:05:37.895Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/interim-approach-evaluating-cardiovascular-risk-new-antidiabetic-therapies-treat-type-2-diabetes-mellitus-notice.html?wbdisable=true
Replay URL: https://replay.healtharchive.ca/job-1/20250419070537/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/interim-approach-evaluating-cardiovascular-risk-new-antidiabetic-therapies-treat-type-2-diabetes-mellitus-notice.html?wbdisable=true#ha_snapshot=216910
ID: 216910
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots